{"id":"https://openalex.org/W2340698646","doi":"https://doi.org/10.1001/jamaoncol.2016.0339","title":"Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial","display_name":"Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial","publication_year":2016,"publication_date":"2016-04-21","ids":{"openalex":"https://openalex.org/W2340698646","doi":"https://doi.org/10.1001/jamaoncol.2016.0339","mag":"2340698646","pmid":"https://pubmed.ncbi.nlm.nih.gov/27100299"},"language":"en","primary_location":{"id":"doi:10.1001/jamaoncol.2016.0339","doi":"https://doi.org/10.1001/jamaoncol.2016.0339","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2016.0339","pdf_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2513897/coi160008.pdf","source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2513897/coi160008.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010278367","display_name":"Sherene Loi","orcid":"https://orcid.org/0000-0001-6137-9171","observed_orcids":["https://orcid.org/0000-0001-6137-9171"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Sherene Loi","raw_affiliation_strings":["Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085173975","display_name":"Urania G. Dafni","orcid":"https://orcid.org/0000-0003-4367-4497","observed_orcids":["https://orcid.org/0000-0003-4367-4497"]},"institutions":[{"id":"https://openalex.org/I4210135765","display_name":"Frontier Science Foundation-Hellas","ror":"https://ror.org/03m2f4c21","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210135765"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Urania Dafni","raw_affiliation_strings":["Frontier Science Foundation\u2013 Hellas, Athens, Greece3University of Athens, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Frontier Science Foundation\u2013 Hellas, Athens, Greece3University of Athens, Athens, Greece","institution_ids":["https://openalex.org/I4210135765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022127552","display_name":"Dimitris Karlis","orcid":"https://orcid.org/0000-0003-3711-1575","observed_orcids":["https://orcid.org/0000-0003-3711-1575"]},"institutions":[{"id":"https://openalex.org/I4210135765","display_name":"Frontier Science Foundation-Hellas","ror":"https://ror.org/03m2f4c21","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210135765"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Dimitris Karlis","raw_affiliation_strings":["Frontier Science Foundation\u2013 Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Frontier Science Foundation\u2013 Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece","institution_ids":["https://openalex.org/I4210135765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032010670","display_name":"Varvara Polydoropoulou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135765","display_name":"Frontier Science Foundation-Hellas","ror":"https://ror.org/03m2f4c21","country_code":"GR","type":"nonprofit","lineage":["https://openalex.org/I4210135765"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Varvara Polydoropoulou","raw_affiliation_strings":["Frontier Science Foundation\u2013 Hellas, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Frontier Science Foundation\u2013 Hellas, Athens, Greece","institution_ids":["https://openalex.org/I4210135765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088338902","display_name":"Brandon Michael Young","orcid":"https://orcid.org/0000-0003-2973-2072","observed_orcids":["https://orcid.org/0000-0003-2973-2072"]},"institutions":[{"id":"https://openalex.org/I2799572201","display_name":"Avera Health","ror":"https://ror.org/05nter171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799572201"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon M. Young","raw_affiliation_strings":["Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota","institution_ids":["https://openalex.org/I2799572201"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113782413","display_name":"Scooter Willis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799572201","display_name":"Avera Health","ror":"https://ror.org/05nter171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799572201"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scooter Willis","raw_affiliation_strings":["Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota","institution_ids":["https://openalex.org/I2799572201"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051184287","display_name":"Bradley C. Long","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley Long","raw_affiliation_strings":["Department of Pathology, University of Chicago, Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, University of Chicago, Chicago, Illinois","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081663693","display_name":"Evandro de Azambuja","orcid":"https://orcid.org/0000-0001-9501-4509","observed_orcids":["https://orcid.org/0000-0001-9501-4509","https://orcid.org/0000-0001-7563-0179"]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Evandro de Azambuja","raw_affiliation_strings":["BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium","institution_ids":["https://openalex.org/I132053463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057269336","display_name":"Christos P. Sotiriou","orcid":"https://orcid.org/0000-0002-5745-9977","observed_orcids":["https://orcid.org/0000-0002-5745-9977"]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Christos Sotiriou","raw_affiliation_strings":["Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium","institution_ids":["https://openalex.org/I132053463","https://openalex.org/I2801838318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088697304","display_name":"Giuseppe Viale","orcid":"https://orcid.org/0000-0003-1882-7068","observed_orcids":["https://orcid.org/0000-0003-1882-7068"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Viale","raw_affiliation_strings":["University of Milan, European Institute of Oncology, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Milan, European Institute of Oncology, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028984477","display_name":"Josef R\u00fcschoff","orcid":"https://orcid.org/0000-0003-1467-8149","observed_orcids":["https://orcid.org/0000-0003-1467-8149"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josef R\u00fcschoff","raw_affiliation_strings":["Targos Molecular Pathology GmbH, Kassel, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Targos Molecular Pathology GmbH, Kassel, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087380706","display_name":"Martine J Piccart","orcid":"https://orcid.org/0000-0001-9068-8504","observed_orcids":["https://orcid.org/0000-0001-9068-8504"]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]},{"id":"https://openalex.org/I35141943","display_name":"Breast International Group","ror":"https://ror.org/0092p0v85","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I35141943"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Martine J. Piccart","raw_affiliation_strings":["Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium","Breast International Group (BIG), Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium","institution_ids":["https://openalex.org/I132053463","https://openalex.org/I2801838318","https://openalex.org/I35141943"]},{"raw_affiliation_string":"Breast International Group (BIG), Brussels, Belgium","institution_ids":["https://openalex.org/I35141943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057689412","display_name":"Mitch Dowsett","orcid":"https://orcid.org/0000-0003-4122-744X","observed_orcids":["https://orcid.org/0000-0003-4122-744X"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mitch Dowsett","raw_affiliation_strings":["Royal Marsden Hospital, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden Hospital, London, England","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062814767","display_name":"Stefan Michiels","orcid":"https://orcid.org/0000-0002-6963-2968","observed_orcids":["https://orcid.org/0000-0002-6963-2968"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210103698","display_name":"Centre de recherche en Epid\u00e9miologie et Sant\u00e9 des Populations","ror":"https://ror.org/01ed4t417","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I195731000","https://openalex.org/I277688954","https://openalex.org/I4210097159","https://openalex.org/I4210103698","https://openalex.org/I4210164847","https://openalex.org/I4405259118"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Stefan Michiels","raw_affiliation_strings":["INSERM U1018 CESP, Service de Biostatistique et d\u2019Epid\u00e9miologie, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U1018 CESP, Service de Biostatistique et d\u2019Epid\u00e9miologie, Villejuif, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210103698"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068271757","display_name":"Brian R Leyland-Jones","orcid":"https://orcid.org/0000-0003-2434-0774","observed_orcids":["https://orcid.org/0000-0003-2434-0774"]},"institutions":[{"id":"https://openalex.org/I2799572201","display_name":"Avera Health","ror":"https://ror.org/05nter171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799572201"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Leyland-Jones","raw_affiliation_strings":["Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota","institution_ids":["https://openalex.org/I2799572201"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5010278367"],"corresponding_institution_ids":["https://openalex.org/I2800555584"],"apc_list":null,"apc_paid":null,"fwci":5.2315,"has_fulltext":true,"cited_by_count":97,"citation_normalized_percentile":{"value":0.97038724,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"2","issue":"8","first_page":"1040","last_page":"1040"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9240000247955322},{"id":"https://openalex.org/keywords/estrogen-receptor","display_name":"estrogen receptor","score":0.7300000190734863},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.8190000057220459},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8960000276565552},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.8759999871253967},{"id":"https://openalex.org/keywords/her2-amplification","display_name":"HER2 amplification","score":0.6629999876022339},{"id":"https://openalex.org/keywords/her2-expression","display_name":"HER2 expression","score":0.593999981880188},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.7850000262260437},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9959999918937683},{"id":"https://openalex.org/keywords/biomarker-interaction","display_name":"biomarker interaction","score":0.48100000619888306},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.6579999923706055},{"id":"https://openalex.org/keywords/fluorescence-in-situ-hybridization","display_name":"fluorescence in situ hybridization","score":0.7089999914169312},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.8539999723434448},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8333226442337036},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8148893117904663},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7007694244384766},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6475611925125122},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5298355221748352},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5209373235702515},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.46044692397117615},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4101850986480713},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2966765761375427},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017404","descriptor_name":"In Situ Hybridization, Fluorescence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D047628","descriptor_name":"Estrogen Receptor alpha","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D047628","descriptor_name":"Estrogen Receptor alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1001/jamaoncol.2016.0339","doi":"https://doi.org/10.1001/jamaoncol.2016.0339","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2016.0339","pdf_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2513897/coi160008.pdf","source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},{"id":"pmid:27100299","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27100299","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA oncology","raw_type":"Journal Article"},{"id":"pmh:oai:dipot.ulb.ac.be:2013/234052","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/234052","pdf_url":null,"source":{"id":"https://openalex.org/S4306401063","display_name":"D\u00e9p\u00f4t institutionnel de l'Universit\u00e9 libre de Bruxelles (Universit\u00e9 Libre de Bruxelles)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I132053463","host_organization_name":"Universit\u00e9 Libre de Bruxelles","host_organization_lineage":["https://openalex.org/I132053463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JAMA oncology","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:zenodo.org:151006","doi":null,"is_oa":true,"landing_page_url":"https://www.openaccessrepository.it/record/151006","pdf_url":null,"source":{"id":"https://openalex.org/S4306402478","display_name":"INFM-OAR (INFN Catania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210116497","host_organization_name":"Istituto Nazionale di Fisica Nucleare, Sezione di Catania","host_organization_lineage":["https://openalex.org/I4210116497"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1001/jamaoncol.2016.0339","doi":"https://doi.org/10.1001/jamaoncol.2016.0339","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2016.0339","pdf_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2513897/coi160008.pdf","source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G356533074","display_name":"NIHR Senior Investigator Award","funder_award_id":"NF-SI-0512-10122","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320334707","display_name":"Cancer Council Victoria","ror":"https://ror.org/023m51b03"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2340698646.pdf","grobid_xml":"https://content.openalex.org/works/W2340698646.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1464936406","https://openalex.org/W1966714873","https://openalex.org/W1998162919","https://openalex.org/W2008557562","https://openalex.org/W2032108920","https://openalex.org/W2037013151","https://openalex.org/W2071066672","https://openalex.org/W2097255042","https://openalex.org/W2105592956","https://openalex.org/W2111578514","https://openalex.org/W2113499049","https://openalex.org/W2117649489","https://openalex.org/W2119878357","https://openalex.org/W2125620887","https://openalex.org/W2145257123","https://openalex.org/W2149908785","https://openalex.org/W2154477838","https://openalex.org/W2157840751","https://openalex.org/W2162982444","https://openalex.org/W2164484108","https://openalex.org/W2165139474","https://openalex.org/W2165249233","https://openalex.org/W2324350519","https://openalex.org/W4294826717","https://openalex.org/W4301159569"],"related_works":["https://openalex.org/W2150086065","https://openalex.org/W3182688946","https://openalex.org/W3093095546","https://openalex.org/W2321625068","https://openalex.org/W2169767645","https://openalex.org/W2310231512","https://openalex.org/W2124414372","https://openalex.org/W4396597683","https://openalex.org/W2165249233","https://openalex.org/W2405243761"],"abstract_inverted_index":{"IMPORTANCE:":[0],"A":[1],"number":[2,121],"of":[3,35,44,51,103,142,170,249,333],"studies":[4],"suggest":[5],"that":[6,74,354,375],"response":[7,408],"to":[8,19,48,88,130,159,176,292,386,409],"antihuman":[9],"epidermal":[10],"growth":[11],"factor":[12],"receptor-2":[13],"(currently":[14],"known":[15],"as":[16,182,417],"ERBB2,":[17],"butreferred":[18],"asHER2":[20],"in":[21,55,114,204,235,258,407,412],"this":[22,36],"study)":[23],"agents":[24,411],"differs":[25],"by":[26,378],"estrogen":[27],"receptor":[28],"(ER)":[29],"level":[30],"status.":[31],"The":[32,65],"clinical":[33],"relevance":[34],"is":[37,99],"unknown.":[38],"OBJECTIVE:":[39],"To":[40],"determine":[41],"the":[42,56,104,198,205,286,334],"magnitude":[43],"trastuzumab":[45,92,133,163,399],"benefit":[46,364,396],"according":[47],"quantitative":[49],"levels":[50,141,360,392],"ER":[52,108,225],"and":[53,86,119,132,144,193,200,214,227,251,269,281],"HER2":[54,112,145,228,252,424],"HERceptin":[57],"Adjuvant":[58],"(HERA)":[59],"trial.":[60],"DESIGN,":[61],"SETTING,":[62],"AND":[63,188,368],"PARTICIPANTS:":[64],"HERA":[66,105],"trial":[67,73],"was":[68,174,245,275,341],"an":[69],"international,":[70],"multicenter,":[71],"randomized":[72,83,129,158],"included":[75],"5099":[76],"patients":[77,127,151,177,260],"with":[78,178,326,357,371,381,389],"early-stage":[79],"HER2-positive":[80,372],"breast":[81,355,373,415],"cancer,":[82],"between":[84],"2001":[85],"2005":[87],"receive":[89,160],"either":[90,161],"no":[91,162],"or":[93,135,164,388],"trastuzumab,":[94],"after":[95,400],"adjuvant":[96,398],"chemotherapy.":[97,401],"This":[98],"a":[100,271,329],"secondary":[101,201],"analysis":[102],"study.":[106],"Local":[107],"immunohistochemical":[109],"(IHC)":[110],"analyses,":[111],"fluorescence":[113],"situ":[115],"hybridization":[116],"(FISH)":[117],"ratio,":[118],"copy":[120,253],"results":[122],"were":[123,147,157,197,219,233,255],"available":[124,148],"for":[125,149,211,267,277,285,299,312,337,346],"3037":[126],"(59.6%)":[128],"observation":[131],"(1":[134],"2":[136,168],"years)":[137],"(cohort":[138,153],"1).":[139],"Transcript":[140],"ESR1":[143,335,359,391],"genes":[146],"615":[150],"(12.1%)":[152],"2).":[154],"INTERVENTIONS:":[155],"Patients":[156,370],"1":[165],"year":[166],"vs":[167],"years":[169],"trastuzumab.":[171,366],"Endocrine":[172],"therapy":[173],"given":[175],"hormone":[179],"receptor-positive":[180],"disease":[181],"per":[183],"local":[184],"guidelines.":[185],"MAIN":[186],"OUTCOMES":[187],"MEASURES:":[189],"Disease-free":[190],"survival":[191,195],"(DFS)":[192],"overall":[194],"(OS)":[196],"primary":[199],"end":[202,339],"points":[203,340],"intent-to-treat":[206],"population":[207],"(ITT).":[208],"Analyses":[209],"adjusting":[210],"crossover":[212],"(censored":[213],"inverse":[215],"probability":[216],"weighted":[217],"[IPW])":[218],"also":[220,342,361],"performed.":[221],"Interactions":[222],"among":[223],"treatment,":[224],"status,":[226],"amplification":[229],"using":[230],"predefined":[231],"cutoffs":[232],"assessed":[234],"Cox":[236],"proportional":[237],"hazards":[238],"regression":[239],"models.":[240],"RESULTS:":[241],"Median":[242],"follow-up":[243],"time":[244],"8":[246],"years.":[247],"Levels":[248],"FISH":[250,282,289,383],"numbers":[254],"significantly":[256,394],"higher":[257,358,390],"ER-negative":[259],"(P":[261],"<":[262],".001).":[263],"In":[264,322],"cohort":[265,323,327],"1,":[266,328],"DFS":[268],"OS,":[270],"significant":[272,330],"treatment":[273],"effect":[274,332],"found":[276],"all":[278],"ER,":[279],"IHC,":[280],"levels,":[283],"except":[284],"ER-positive/HER2":[287],"low":[288,382],"ratio":[290,384],"(\u22652":[291,385],"<5)":[293],"group":[294],"(DFS:":[295],"3-way":[296],"ITT":[297,310],"Pvalue":[298,311,345],"interaction":[300,313,347],"=":[301,304,307,314,317,320,348,351],".07;":[302],"censored":[303,316],".02;":[305],"IPW":[306,319],".03;":[308],"OS":[309,350],".007;":[315],".04;":[318],".03).":[321],"2,":[324],"consistent":[325],"predictive":[331],"gene":[336],"both":[338],"observed":[343],"(DFS":[344],".06;":[349],".02),":[352],"indicating":[353],"cancers":[356,374,416],"derive":[362,393],"less":[363,395],"from":[365,397],"CONCLUSIONS":[367],"RELEVANCE:":[369],"are":[376],"ER-positive":[377,414],"IHC":[379],"analyses":[380],"<5),":[387],"These":[402],"data":[403],"may":[404,419],"explain":[405],"heterogeneity":[406],"anti-HER2":[410],"HER2-positive,":[413],"some":[418],"be":[420],"more":[421],"luminal-like":[422],"than":[423],"driven.":[425],"TRIAL":[426],"REGISTRATION:":[427],"clinicaltrials.gov":[428],"Identifier:":[429],"NCT00045032.":[430]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":5}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}